{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:30:39Z","timestamp":1792665039835,"version":"4.5.0"},"reference-count":13,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","aaojournal.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.ophtha.2014.11.029","type":"journal-article","created":{"date-parts":[[2015,1,21]],"date-time":"2015-01-21T05:02:25Z","timestamp":1421816545000},"page":"1016-1022","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Efficacy and Toxicity of Second-Course Ophthalmic Artery Chemosurgery for Retinoblastoma"],"prefix":"10.1016","volume":"122","author":[{"given":"Jasmine H.","family":"Francis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Abramson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y. Pierre","family":"Gobin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian P.","family":"Marr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irwin","family":"Tendler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott E.","family":"Brodie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ira J.","family":"Dunkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2014.11.029_bib1","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1001\/archopht.1982.01030040235004","article-title":"Retreatment of retinoblastoma with external beam irradiation","volume":"100","author":"Abramson","year":"1982","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.11.029_bib2","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1136\/bjophthalmol-2013-303267","article-title":"Intra-arterial chemotherapy with melphalan for intraocular retinoblastoma","volume":"97","author":"Bracco","year":"2013","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.11.029_bib3","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.ophtha.2014.01.026","article-title":"Intra-arterial chemotherapy for retinoblastoma in 70 eyes: outcomes based on the international classification of retinoblastoma","volume":"121","author":"Shields","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2014.11.029_bib4","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1097\/IAE.0b013e318295f783","article-title":"Management of advanced retinoblastoma with intravenous chemotherapy then intra-arterial chemotherapy as alternative to enucleation","volume":"33","author":"Shields","year":"2013","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2014.11.029_bib5","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S1470-2045(09)70136-6","article-title":"Is there a role for second-line chemotherapy in advanced gastric cancer?","volume":"10","author":"Wesolowski","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ophtha.2014.11.029_bib6","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1651-2227.2004.tb03048.x","article-title":"Ifosfamide\/carboplatin\/etoposide (ICE) as front-line, topotecan\/cyclophosphamide as second-line and oral temozolomide as third-line treatment for advanced neuroblastoma over one year of age","volume":"93","author":"Donfrancesco","year":"2004","journal-title":"Acta Paediatr Suppl"},{"key":"10.1016\/j.ophtha.2014.11.029_bib7","doi-asserted-by":"crossref","first-page":"749","DOI":"10.3892\/mco.2013.115","article-title":"Phase II study on the combination of irinotecan plus cisplatin as a second-line therapy in patients with advanced or recurrent gastric cancer","volume":"1","author":"Rino","year":"2013","journal-title":"Mol Clin Oncol"},{"key":"10.1016\/j.ophtha.2014.11.029_bib8","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1001\/archophthalmol.2011.5","article-title":"Intra-arterial chemotherapy for the management of retinoblastoma: four-year experience","volume":"129","author":"Gobin","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.11.029_bib9","doi-asserted-by":"crossref","first-page":"e44322","DOI":"10.1371\/journal.pone.0044322","article-title":"Combined, sequential intravenous and intra-arterial chemotherapy (bridge chemotherapy) for young infants with retinoblastoma","volume":"7","author":"Gobin","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ophtha.2014.11.029_bib10","doi-asserted-by":"crossref","first-page":"e84247","DOI":"10.1371\/journal.pone.0084247","article-title":"Electroretinogram monitoring of dose-dependent toxicity after ophthalmic artery chemosurgery in retinoblastoma eyes: six year review","volume":"9","author":"Francis","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ophtha.2014.11.029_bib11","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1136\/bjophthalmol-2011-301450","article-title":"Intravitreal chemotherapy for vitreous disease in retinoblastoma revisited: from prohibition to conditional indications","volume":"96","author":"Munier","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.11.029_bib12","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1001\/jamaophthalmol.2013.7666","article-title":"Intravitreal melphalan for persistent or recurrent retinoblastoma vitreous seeds: preliminary results","volume":"132","author":"Shields","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.11.029_bib13","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1016\/j.ophtha.2014.03.028","article-title":"Local and systemic toxicity of intravitreal melphalan for vitreous seeding in retinoblastoma: a preclinical and clinical study","volume":"121","author":"Francis","year":"2014","journal-title":"Ophthalmology"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642014011361?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642014011361?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T22:55:14Z","timestamp":1566255314000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642014011361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":13,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0161642014011361"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2014.11.029","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and Toxicity of Second-Course Ophthalmic Artery Chemosurgery for Retinoblastoma","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2014.11.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}